361 related articles for article (PubMed ID: 33021430)
1. Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer.
Das A; Cohen JE; Ko OS; Jordan BJ; Glaser AP; Auffenberg GB; Meeks JJ
J Urol; 2021 Mar; 205(3):693-700. PubMed ID: 33021430
[TBL] [Abstract][Full Text] [Related]
2. Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
Fujita N; Hatakeyama S; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
Urol Oncol; 2020 Oct; 38(10):795.e9-795.e17. PubMed ID: 32417111
[TBL] [Abstract][Full Text] [Related]
3. Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
Blute ML; Rushmer TJ; Shi F; Fuller BJ; Abel EJ; Jarrard DF; Downs TM
J Urol; 2015 Nov; 194(5):1214-9. PubMed ID: 26173101
[TBL] [Abstract][Full Text] [Related]
4. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
[TBL] [Abstract][Full Text] [Related]
5. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
Richards KA; Smith ND; Steinberg GD
J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
7. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
[TBL] [Abstract][Full Text] [Related]
8. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
9.
Yanagisawa T; Mori K; Motlagh RS; Kawada T; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; D'Andrea D; Compérat E; Miki J; Kimura T; Egawa S; Shariat SF
J Urol; 2022 Apr; 207(4):754-768. PubMed ID: 35060770
[TBL] [Abstract][Full Text] [Related]
10. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.
Rouprêt M; Yates DR; Varinot J; Phé V; Chartier-Kastler E; Bitker MO; Compérat E
Can J Urol; 2012 Oct; 19(5):6459-64. PubMed ID: 23040628
[TBL] [Abstract][Full Text] [Related]
11. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of simultaneous transurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.
Ham WS; Kim WT; Jeon HJ; Lee DH; Choi YD
J Urol; 2009 Apr; 181(4):1594-9; discussion 1599. PubMed ID: 19230913
[TBL] [Abstract][Full Text] [Related]
13. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
[TBL] [Abstract][Full Text] [Related]
14. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
[TBL] [Abstract][Full Text] [Related]
15. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
Mariappan P; Zachou A; Grigor KM;
Eur Urol; 2010 May; 57(5):843-9. PubMed ID: 19524354
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Detrusor Muscle Sampling Rate in Monopolar and Bipolar Transurethral Resection of Bladder Tumor: A Randomized Trial.
Teoh JY; Chan ES; Yip SY; Tam HM; Chiu PK; Yee CH; Wong HM; Chan CK; Hou SS; Ng CF
Ann Surg Oncol; 2017 May; 24(5):1428-1434. PubMed ID: 27882470
[TBL] [Abstract][Full Text] [Related]
17. Spinal Anesthesia is Associated with Lower Recurrence Rates after Resection of Nonmuscle Invasive Bladder Cancer.
Koumpan Y; Jaeger M; Mizubuti GB; Tanzola R; Jain K; Hosier G; Hopman W; Siemens DR
J Urol; 2018 Apr; 199(4):940-946. PubMed ID: 29154849
[TBL] [Abstract][Full Text] [Related]
18. Vertical Lamina Propria Invasion Diagnosed by En Bloc Transurethral Resection is a Significant Predictor of Progression for pT1 Bladder Cancer.
Yanagisawa T; Miki J; Yorozu T; Iwatani K; Obayashi K; Sato S; Kimura T; Takahashi H; Egawa S
J Urol; 2021 Jun; 205(6):1622-1628. PubMed ID: 33502235
[TBL] [Abstract][Full Text] [Related]
19. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.
Zehnder P; Thalmann GN
Curr Opin Urol; 2013 Sep; 23(5):423-8. PubMed ID: 23880740
[TBL] [Abstract][Full Text] [Related]
20. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
